Author - Reema Parmar

Bringing healing into focus

Why do some patients receiving hemodialysis remain cheerful, hopeful, outward-looking, and enjoy a rich life, while others suffer debilitating depression and other emotional problems? Can whatever makes some patients more resilient be “bottled” and given to those less resilient to help them? These are the questions that Chris McIntyre, professor of medicine, medical biophysics, and...

Lifelong personalized plans for vascular access in hemodialysis patients

Hemodialysis is life-sustaining therapy for many patients with chronic kidney disease, but choosing how to access a patient’s blood for treatment presents pros and cons, depending on their situation. “We have seen that a ‘one-size-fits-all’ approach to medicine, and for hemodialysis vascular access, does not necessarily work for all,” says Charmaine Lok, Professor of Medicine...

Building a network to investigate CKD risk factors in Africa

It is well-established that African Americans are more than three times as likely to develop end-stage renal disease (ESRD) than non-Hispanic white Americans. Research also shows that Black people living in sub-Saharan Africa have a similarly high predisposition to developing chronic kidney disease (CKD). “This increased risk of CKD is attributable in part to variants...

ISN President to Present Key Recommendations at PHSSR Summit

The Partnership for Health System Sustainability Resilience (PHSSR), founded by the World Economic Forum (WEF), the London School of Economics, and AstraZeneca, is holding a summit from March 15-19 2021. Registration details to follow shortly. “Improving the effectiveness of care” will bring together academia and the public and private sectors to share insights from nine months...

ISN-NEPHJC Collaboration: The #NephTrials Initiative – Join the Conversation on February 16 @ 9 p.m. ET

Help expand trial participation within the nephrology community: Join colleagues online for a lively exchange of ideas on February 16 at 9 p.m. ET. #NephTrials The ISN-ACT (Advancing Clinical Trials) and NephJC are partnering on the #NephTrials initiative to increase awareness of ongoing trials in nephrology and improve understanding of what it takes to design and conduct clinical trials. The #NephTrials initiative is an exciting new series...

Celebrating ISN Collective-Member Societies: The Swiss Society of Nephrology

Throughout 2021, the ISN will present a series of interviews with our Collective-Member Societies. For this edition, we interviewed Rudolf P. Wüthrich, President of the Swiss Society of Nephrology. This society has been an ISN Collective-Member for over a decade. In 2019, the ISN launched a new partnership with the Swiss Society of Nephrology and the...

ISN Global Trials Focus

Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. Highlights: Daily, weekly, or monthly cholecalciferol dosing regimens are similarly effective in children with CKD View the latest trials here. A summary of the highlighted trial is now available in French, Mandarin, Russian, and Spanish. Support equal access to nephrology research: Become an ISN...

Get Support For Your 2021 Research Project: Apply to the ISN Clinical Research Program

The ISN Clinical Research Program supports research and education programs in low-to-middle income countries that help detect and manage non-communicable chronic diseases such as CKD, AKI, hypertension, diabetes, and cardiovascular disease. The deadline for online submission of proposals is May 1, 2021. Proposals are reviewed by an ISN for approval before they are submitted online. To...